Sudoscan to Exhibit at EFAS 2025 in Toulouse, France

Sudoscan is pleased to announce its participation in the 26th Congress of the European Federation of Autonomic Societies (EFAS), taking place from 25–27 September 2025 at the Centre d’Enseignement et des Congrès (CEC), Purpan Hospital, Toulouse, France.

About EFAS 2025

Hosted by CESNA, the French Autonomic Nervous System Society, this congress will bring together leading international specialists to present the latest advances in autonomic medicine. The scientific programme will cover the full spectrum of neurological specialties and explore new physiopathological approaches, with a strong translational focus.
Highlights include a special session on autonomic nervous system assessment in sport and extreme environments, prizes to promote excellence, and a welcoming, inclusive atmosphere designed to foster collaboration, education, and clinical research.

Endorsed by the European Academy of Neurology (EAN), EFAS 2025 promises to be a major event for scientists and clinicians dedicated to advancing knowledge in autonomic neuroscience, a mission that Sudoscan also supports through its innovative technology.

If you want to learn more about the program of the 2025 EFAS Conference, click here.

Sudoscan: Fast, Non-Invasive Autonomic Testing

As an innovator in the field of autonomic testing, Sudoscan is aligned with EFAS’s mission to advance research and improve clinical practice. Sudoscan is a CE-marked and FDA-cleared Class IIa medical device designed to assess sudomotor function, a reliable marker of small fiber and autonomic nerve health. The test is:
• Fast: results in under three minutes, without patient preparation,
• Non-invasive: safe, painless, and easy to perform,
• Evidence-based: supported by more than 150 peer-reviewed scientific publications.

By providing quantitative and reproducible results, Sudoscan helps clinicians detect early signs of autonomic dysfunction and monitor disease progression across multiple specialties, including neurology, diabetology, nephrology, and oncology.

For more studies on the efficacy of Sudoscan’s technology in neurological diseases, visit our publications page.

Meet Sudoscan at EFAS 2025

We look forward to welcoming attendees at the exhibition area in Toulouse. Visit our booth to:
• Experience live demonstrations of the Sudoscan device,
• Discover how it can be seamlessly integrated into clinical and research workflows,
• Exchange with our experts on practical applications and patient care strategies.

Whether you are a neurologist, researcher, or healthcare professional, Sudoscan offers valuable insights into the evaluation of autonomic and small fiber function, helping to translate cutting-edge research into improved patient outcomes.

For more details about the congress and registration, please visit the official EFAS 2025 website.

 

Share This information, Choose Your Platform!